BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11842024)

  • 1. Alteration of contractile force and mass in the senescent diaphragm with beta(2)-agonist treatment.
    Smith WN; Dirks A; Sugiura T; Muller S; Scarpace P; Powers SK
    J Appl Physiol (1985); 2002 Mar; 92(3):941-8. PubMed ID: 11842024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
    Chen KD; Alway SE
    J Appl Physiol (1985); 2000 Aug; 89(2):606-12. PubMed ID: 10926644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related increases in diaphragmatic maximal shortening velocity.
    Powers SK; Criswell D; Herb RA; Demirel H; Dodd S
    J Appl Physiol (1985); 1996 Feb; 80(2):445-51. PubMed ID: 8929582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of clenbuterol and cyclosporin A on the myosin heavy chain mRNA level and the muscle mass in rat masseter.
    Arai C; Ohnuki Y; Umeki D; Hirashita A; Saeki Y
    J Physiol Sci; 2006 Jun; 56(3):205-9. PubMed ID: 16839454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
    Bricout VA; Serrurier BD; Bigard AX
    Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of specific force deficit in the senescent rat diaphragm.
    Criswell DS; Powers SK; Herb RA; Dodd SL
    Respir Physiol; 1997 Feb; 107(2):149-55. PubMed ID: 9108628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related changes in diaphragm muscle contractile properties and myosin heavy chain isoforms.
    Gosselin LE; Johnson BD; Sieck GC
    Am J Respir Crit Care Med; 1994 Jul; 150(1):174-8. PubMed ID: 8025746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of clenbuterol on diaphragm morphology and contractile properties in emphysematous hamsters.
    Van Der Heijden HF; Dekhuijzen PN; Folgering H; Ginsel LA; Van Herwaarden CL
    J Appl Physiol (1985); 1998 Jul; 85(1):215-22. PubMed ID: 9655778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
    Dodd SL; Koesterer TJ
    Aviat Space Environ Med; 2002 Jul; 73(7):635-9. PubMed ID: 12137098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the beta 2-adrenergic agonist clenbuterol on capillary geometry in cardiac and skeletal muscles in young and middle-aged rats.
    Suzuki J; Gao M; Xie Z; Koyama T
    Acta Physiol Scand; 1997 Nov; 161(3):317-26. PubMed ID: 9401584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
    Py G; Ramonatxo C; Sirvent P; Sanchez AM; Philippe AG; Douillard A; Galbès O; Lionne C; Bonnieu A; Chopard A; Cazorla O; Lacampagne A; Candau RB
    J Physiol; 2015 Apr; 593(8):2071-84. PubMed ID: 25656230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced alterations in the rate of diaphragmatic fatigue.
    Fletcher LK; Powers SK; Coombes JS; Demirel H; Vincent H; Dodd SL; Mclaughlin J
    Pharmacol Res; 2000 Jul; 42(1):61-8. PubMed ID: 10860636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.
    Chen KD; Alway SE
    Muscle Nerve; 2001 Feb; 24(2):211-22. PubMed ID: 11180204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats.
    Carter WJ; Lynch ME
    Metabolism; 1994 Sep; 43(9):1119-25. PubMed ID: 7916118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres.
    Oishi Y; Imoto K; Ogata T; Taniguchi K; Matsumoto H; Roy RR
    Acta Physiol Scand; 2002 Dec; 176(4):311-8. PubMed ID: 12444937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle.
    Dodd SL; Powers SK; Vrabas IS; Criswell D; Stetson S; Hussain R
    Med Sci Sports Exerc; 1996 Jun; 28(6):669-76. PubMed ID: 8784754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic and inotropic effects of K+-channel blockade in aged diaphragm.
    van LUNTEREN E; Moyer M
    Am J Respir Crit Care Med; 1998 Sep; 158(3):820-6. PubMed ID: 9731011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats.
    Carter WJ; Dang AQ; Faas FH; Lynch ME
    Metabolism; 1991 Aug; 40(8):855-60. PubMed ID: 1861634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-long calorie restriction in Fischer 344 rats attenuates age-related loss in skeletal muscle-specific force and reduces extracellular space.
    Payne AM; Dodd SL; Leeuwenburgh C
    J Appl Physiol (1985); 2003 Dec; 95(6):2554-62. PubMed ID: 12972444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in diaphragmatic oxidative and antioxidant enzymes in the senescent Fischer 344 rat.
    Powers SK; Lawler J; Criswell D; Lieu FK; Dodd S
    J Appl Physiol (1985); 1992 Jun; 72(6):2317-21. PubMed ID: 1629087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.